UnknownNot Applicable

Incidence and Clinical Characteristics of Pulmonary Hypertension Secondary to ARDS in the Highland

China100 participantsStarted 2021-11-25

Plain-language summary

The study is conducted in the affiliated hospital of Qinghai University .Patients in the department of Critical Care Medicine and Emergency Intensive Care Unit will be eligible for inclusion if they meet the Berlin criteria.Two researchers assess pulmonary artery pressure and right heart function of patients who are enrolled.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Inclusion Criteria: 18 to 80 years of age Meet the diagnostic criteria Receive invasive mechanical ventilation within 48 hours \- Exclusion Criteria: Patients with those disease will be excluded ： chronic obstructive pulmonary disease Pulmonary embolism Chronic heart failure Idiopathic pulmonary fibrosis Pulmonary hypertension Pregnant women will be excluded too. \-

What they're measuring

Incidence of Pulmonary Hypertension Secondary to ARDS in the Highland

Timeframe: 20/11/2021-20/12/2022

ICU mortality ICU mortality

Timeframe: 20/11/2021-20/12/2022

28-days mortality rate

Timeframe: 20/11/2021-20/12/2022

Trial details

NCT IDNCT05166759

SponsorSoutheast University, China

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-03

Contact for this trial

Chun Pan, MD

13814009925 panchun1982@gmail.com

View on ClinicalTrials.gov More ARDS trials